Tuesday 17 November 2026
Export KYNB’s income statement to Excel — free account
Kyntra Bio Inc
KYNBKyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.
- Revenue
- n/m
- EPS
- n/m
- Free cash flow
- n/m
Quarter to June 2026, against a year earlier
3.11
0.33
−9.59%
Follow KYNB
Alert me
Where the cash went Fiscal 2025, year to 31 December 2025
Free cash flow was −$4.8M: capital expenditures were more than operating cash flow. Cash fell by $54.3M. Lines the picture does not name came to −$4.4M. What is a cash flow statement?
- Free cash flow
- −$4.8M
- Returned to shareholders
- $0.00
- Debt, net
- −$80.6M repaid
- Change in cash
- −$54.3M over the period
| Operating cash flow | 0.0 |
|---|---|
| Capital expenditures | 0.0 |
| Free cash flow | 0.0 |
| Acquisitions, net | +0.1 |
| Into investments, net | −0.1 |
| Debt repaid, net | −0.1 |
| Other | 0.0 |
| Change in cash | −0.1 |
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $0.0B | −$0.1B | −$0.1B | −$0.1B | $0.1B | −$0.1B | −$0.1B | −$0.3B | −$0.1B | $0.0B |
| Capex | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Free cash flow | $0.0B | −$0.1B | −$0.1B | −$0.1B | $0.1B | −$0.1B | −$0.1B | −$0.3B | −$0.1B | $0.0B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
183.45 | (47.58) | (284.23) | (293.65) | (290.02) | (189.29) | (76.97) | (86.42) | (120.87) | (58.07) |
Depreciation & Amortization |
0.68 | 1.01 | 4.87 | 12.22 | 17.29 | 22.15 | 17.79 | 6.52 | 7.94 | 8.77 |
Non Cash Items (Other) |
(35.87) | 26.03 | 84.03 | 65.07 | 130.42 | 74.11 | 66.14 | 52.15 | 37.40 | 31.88 |
Accounts Receivable Change |
(2.54) | (6.74) | 3.43 | 0.77 | 25.18 | (11.97) | 35.23 | (55.23) | 2.00 | 4.96 |
Change in inventories |
5.36 | 22.28 | (1.69) | (11.00) | (14.16) | (9.17) | (6.89) | — | — | — |
Accounts Payable Change |
(27.65) | 14.51 | (15.51) | 5.91 | 0.81 | 17.73 | (3.05) | 3.63 | (0.71) | (0.30) |
Change in payables and accrued liability |
(45.51) | (91.53) | (49.78) | 90.56 | 16.38 | 30.91 | 17.71 | 5.61 | 9.20 | 2.97 |
Change in other assets and liabilities |
(82.69) | (55.98) | (56.13) | (15.80) | 31.88 | 147.13 | (128.66) | (2.40) | (1.46) | 16.90 |
Operating Cash Flow |
(4.77) | (138.00) | (315.02) | (145.93) | (82.23) | 81.60 | (78.70) | (76.14) | (66.51) | 7.11 |
Capital expenditures |
(0.04) | 0.78 | (2.52) | (3.73) | (5.19) | (3.99) | (5.75) | (7.84) | (8.49) | (1.25) |
Change in intangibles (net) |
— | — | — | (35.00) | (25.00) | 0.00 | — | — | — | — |
Net Aquisitions |
96.62 | — | — | — | — | — | — | — | — | — |
Short Term Investments Change (Net) |
(61.16) | (8.63) | (245.10) | (156.64) | (479.93) | 2.41 | (411.30) | (576.88) | (0.17) | 7.87 |
Long-Term Investments Change (Net) |
— | 133.84 | 400.62 | 284.49 | 83.14 | 454.07 | 537.07 | 62.59 | 78.53 | — |
Other investing activities |
— | — | 0.66 | 8.13 | (32.37) | (11.46) | (12.75) | (15.61) | (9.24) | (2.74) |
Investing cash flow |
35.42 | 125.99 | 153.66 | 89.12 | (426.97) | 452.49 | 120.02 | (522.12) | 69.87 | 6.62 |
Repayment/Issuance of Debt (Net) |
(80.56) | (0.04) | 73.59 | (0.54) | (5.89) | (13.02) | (12.33) | (0.36) | (0.40) | (0.40) |
Equity Repurchase (Common, Net) |
— | 0.14 | 52.14 | 4.18 | 12.70 | 37.83 | 20.78 | 29.85 | 506.12 | 9.88 |
Other financial activities |
(5.47) | (0.35) | (2.98) | 43.13 | (7.37) | (11.46) | (12.75) | (15.61) | (9.24) | (2.74) |
Financing cash flow |
(86.03) | (0.25) | 122.75 | 46.78 | (0.56) | 13.34 | (4.30) | 13.88 | 496.47 | 6.74 |
Exchange Rate Adjustment |
1.08 | 0.75 | (3.40) | (5.48) | 2.60 | 4.70 | 0.00 | (0.01) | 0.05 | (0.01) |
Change in Cash |
(54.31) | (11.51) | (42.01) | (15.52) | (507.17) | 552.13 | 37.01 | (584.40) | 499.88 | 20.46 |
Beginning Cash |
102.18 | 113.69 | 155.70 | 171.22 | 678.39 | 126.27 | 89.26 | 673.66 | 173.78 | 153.32 |
Ending Cash |
47.87 | 102.18 | 113.69 | 155.70 | 171.22 | 678.39 | 126.27 | 89.26 | 673.66 | 173.78 |
Stock Based Compensation |
6.58 | 25.22 | 50.77 | 65.60 | 71.16 | 72.72 | 66.27 | 52.14 | 37.54 | 32.13 |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(153.03) | (117.46) | (119.69) | 70.43 | 60.08 | 174.63 | (85.66) | (48.40) | 9.02 | 24.52 |
Investments Change (Net) |
(61.16) | 125.21 | 155.52 | 127.85 | (396.79) | 456.48 | 125.77 | (514.29) | 78.36 | 7.87 |
Issuance/Purchase of Shares |
— | 0.14 | 52.14 | 4.18 | 12.70 | 37.83 | 20.78 | 29.85 | 506.12 | 9.88 |
| Other line items | ||||||||||
Revenue per Employee |
0.19 | 0.13 | 0.10 | 0.24 | 0.42 | 0.29 | 0.48 | 0.46 | 0.31 | 0.50 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026